Oct 24 (Reuters) – CSPC Pharmaceutical Group Ltd : * SYH2061 INJECTION OBTAINS CLINICAL TRIAL APPROVAL IN CHINA Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

The post BRIEF-CSPC Pharmaceutical Says SYH2061 Injection Obtains Clinical Trial Approval In China appeared first on The Sunday Guardian.

See Full Page